• OPEN AN ACCOUNT
Indian Indices
Sensex
84,065.75 485.35
( 0.58%)
Global Indices
Nasdaq
50,145.69 1,215.96
(2.49%)
Dow Jones
6,954.50 135.10
(1.98%)
Hang Seng
56,676.08 2,422.40
(4.46%)
Nikkei 225
10,359.93 50.71
(0.49%)
Forex
USD-INR
90.32 -0.07
(-0.08%)
EUR-INR
106.52 -0.28
(-0.26%)
GBP-INR
122.68 -1.05
(-0.85%)
JPY-INR
0.58 0.00
(-0.33%)

EQUITY - MARKET SCREENER

Tata Consultancy Services Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
532540
INE467B01029
232.8434797
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TCS
21.79
1064242.35
EPS(TTM)
Face Value()
Div & Yield %
134.98
1
4.29
 

LTTS collaborates with NVIDIA to unveil AI-power respiratory diagnostics
Dec 01,2025
L&T Technology Services (LTTS) announced the development of a next-gen AI-powered digital twin platform for respiratory diagnostics and lung navigation.

Combining LTTS' expertise in platform engineering, AI-driven diagnostics, connected health systems and advanced imaging and visualization with cutting edge NVIDIA AI infrastructure, LTTS aims to deliver scalable, low-latency solutions that enhance diagnostic precision and improve accessibility for healthcare providers worldwide.

To be unveiled at the Radiological Society of North America (RSNA) 2025, the LTTS solution integrates with CT imaging and leverages deep learning models to create a 3D digital twin of lung anatomy, providing visualization of airways, blood vessels, lung lobes and lesions. Powered by NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference, the biological digital twin enables interactive visualization, precise path planning and navigation support for bronchoscopy, helping clinicians navigate complex procedures with greater efficiency.

LTTS' deep domain engineering expertise in medical imaging and proprietary navigation systems ensures the platform transforms the snapshots taken into living breathing models that evolve with the patient, delivering intuitive, clinically meaningful simulations that mirror real-world anatomy. This helps transform surgical planning and advancing care for serious conditions such as lung cancer, COPD and infectious diseases.